TABLE 2.
Epilepsy syndromes | N | % |
---|---|---|
WS | 32 | 26.7 |
GTCSA | 26 | 21.7 |
SLCECTS | 15 | 12.5 |
CAE | 12 | 10.0 |
LGS | 12 | 10.0 |
SLFIE | 5 | 4.2 |
JME | 4 | 3.3 |
GEFS+ | 2 | 1.7 |
MTLE | 2 | 1.7 |
EMA | 1 | 0.8 |
PME | 1 | 0.8 |
CSWS | 1 | 0.8 |
Other DEEs a | 7 | 5.8 |
Total | 120 | 100.0 |
Abbreviations: CAE, childhood absence epilepsy; CSWS, epileptic encephalopathy with continuous spike‐and‐wave during sleep; DEE, developmental and epileptic encephalopathy; EMA, epilepsy with myoclonic absences; GEFS+, genetic epilepsy with febrile seizure plus; GTCSA, generalized tonic‐clonic seizures alone; JME, juvenile myoclonic epilepsy; LGS, Lennox‐Gastaut syndrome; MTLE, mesial temporal lobe epilepsy; N, number; PME, progressive myoclonus epilepsy; SLCECTS, self‐limited childhood epilepsy with centrotemporal spikes; SLFIE, self‐limited familial infantile epilepsy; WS, West syndrome.
Other DEEs, Rett syndrome (2, 1.6%), Dravet syndrome (1, 0.8%), Landau‐Kleffner syndrome (1, 0.8%), and unknown cause (3, 2.5%).